HBK Investments’s Repligen RGEN Stock Holding History

HBK Investments’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,911	Closed	-$309K	–	1092
2015 Q4	$309K	Buy	+10,911	New	+$315K	﹤0.01%	855

Other funds holding RGEN

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

HBK Investments's RGEN Position: Q1 2016 in Review

HBK Investments sold out of Repligen (RGEN) in Q1 2016, closing a stake of 10,911 shares — an estimated $309K sold.

HBK Investments first reported a position in RGEN in Q4 2015 and held it in 1 quarter. The position peaked at $309K in Q4 2015. 183 funds tracked by Wall St. Rank hold RGEN as of Q1 2016.

HBK Investments reported no remaining Repligen position as of Q1 2016 after selling out during the quarter.
HBK Investments sold 10,911 Repligen shares in Q1 2016, an estimated $309K.
HBK Investments first reported a position in Repligen in Q4 2015 and held it in 1 quarter.
HBK Investments's Repligen position peaked at $309K in Q4 2015.
183 funds tracked by Wall St. Rank held Repligen as of Q1 2016.

Based on HBK Investments's 13F filing for Q1 2016, filed 13 May 2016.